Geriatric Healthcare Specialist Allison Park PA

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Janet Dolores Vlha
(412) 366-7070
9104 Babcock Blvd
Pittsburgh, PA
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Karen Ann Powers, MD
(412) 232-7170
240 Partridge Run Rd
Gibsonia, PA
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Pa State Univ Coll Of Med, Hershey Pa 17033
Graduation Year: 1984

Data Provided by:
Charles W Mackett, MD
(412) 963-1443
403 Jamesborough Dr
Pittsburgh, PA
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Syracuse, Coll Of Med, Syracuse Ny 13210
Graduation Year: 1982

Data Provided by:
Diane Balestrino
(412) 784-5050
100 Delafield Rd
Pittsburgh, PA
Specialty
Geriatric Medicine

Data Provided by:
Joan M Devine, MD
(412) 781-8566
241 Freeport Rd
Pittsburgh, PA
Specialties
Internal Medicine, Geriatrics
Gender
Male
Education
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburg
Graduation Year: 1980

Data Provided by:
James W Boyle
(412) 366-6841
9104 Babcock Blvd
Pittsburgh, PA
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Rajkumar R Sarma, MD
(412) 782-1000
309 Marberry Dr
Pittsburgh, PA
Specialties
Geriatrics, Geriatric Psychiatry
Gender
Male
Education
Medical School: Mr Med Coll, Gulbarga Univ, Gulbarga, Karnataka, India
Graduation Year: 1988

Data Provided by:
Karen A Powers
(412) 784-5050
100 Delafield Rd
Pittsburgh, PA
Specialty
Geriatric Medicine

Data Provided by:
Cynthia N Rosenberg, MD
(412) 781-8731
PO Box 38607
Pittsburgh, PA
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Female
Education
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburgh Pa 15261
Graduation Year: 1982
Hospital
Hospital: Upmc St Margaret Memorial Hosp, Pittsburgh, Pa; Western Pennsylvania Hospital, Pittsburgh, Pa
Group Practice: West Penn Medical Associates Pc

Data Provided by:
Bhanu S Alapati, MD
100 Delafield Rd Ste 105
Pittsburgh, PA
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Female
Education
Medical School: Bldea Sri Bm Patil Med Coll, Karnataka Univ, Bijapur, Karnataka
Graduation Year: 1994

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...

Click here to read more from Natural Solutions